F. Tas Et Al. , "Circulating levels of vascular endothelial growth factor (VEGF), matrix metalloproteinase-3 (MMP-3), and BCL-2 in malignant melanoma," MEDICAL ONCOLOGY , vol.25, no.4, pp.431-436, 2008
Tas, F. Et Al. 2008. Circulating levels of vascular endothelial growth factor (VEGF), matrix metalloproteinase-3 (MMP-3), and BCL-2 in malignant melanoma. MEDICAL ONCOLOGY , vol.25, no.4 , 431-436.
Tas, F., Duranyildiz, D., Oguz, H., Camlica, H., Yasasever, V., & Topuz, E., (2008). Circulating levels of vascular endothelial growth factor (VEGF), matrix metalloproteinase-3 (MMP-3), and BCL-2 in malignant melanoma. MEDICAL ONCOLOGY , vol.25, no.4, 431-436.
Tas, Faruk Et Al. "Circulating levels of vascular endothelial growth factor (VEGF), matrix metalloproteinase-3 (MMP-3), and BCL-2 in malignant melanoma," MEDICAL ONCOLOGY , vol.25, no.4, 431-436, 2008
Tas, Faruk Et Al. "Circulating levels of vascular endothelial growth factor (VEGF), matrix metalloproteinase-3 (MMP-3), and BCL-2 in malignant melanoma." MEDICAL ONCOLOGY , vol.25, no.4, pp.431-436, 2008
Tas, F. Et Al. (2008) . "Circulating levels of vascular endothelial growth factor (VEGF), matrix metalloproteinase-3 (MMP-3), and BCL-2 in malignant melanoma." MEDICAL ONCOLOGY , vol.25, no.4, pp.431-436.
@article{article, author={Faruk TAŞ Et Al. }, title={Circulating levels of vascular endothelial growth factor (VEGF), matrix metalloproteinase-3 (MMP-3), and BCL-2 in malignant melanoma}, journal={MEDICAL ONCOLOGY}, year=2008, pages={431-436} }